Comparison and Analysis of Antibiotic Consumption in Two Italian Hospital Settings in Relation to the Fight of Antimicrobial Resistance

Author:

Ferrara Francesco1ORCID,Pasquinucci Roberta1,Capuozzo Maurizio1ORCID,Polito Giacomo2ORCID,Bagaglini Gabriele3,Vaccaro Marcello2ORCID,Coluccia Adriana2,Langella Roberto4,Trama Ugo5,Nava Eduardo1,Zovi Andrea6ORCID

Affiliation:

1. Pharmacy Unit, ASL Napoli 3 Sud, 80035 Naples, Italy

2. Pharmacy Unit, Pharmacy Department, Policlinico Umberto I, 00161 Rome, Italy

3. Pharmacy Unit, ASL Latina, 04100 Latina, Italy

4. Italian Society of Hospital Pharmacy (SIFO), SIFO Secretariat of the Lombardy Region, 20159 Milan, Italy

5. Health Protection and Coordination of the Campania Regional Health System, 80143 Naples, Italy

6. Ministry of Health, 00144 Rome, Italy

Abstract

Introduction: The emergence and spread of drug-resistant pathogens due to the improper use of antibiotics have become increasingly apparent in recent years. Objective: This retrospective comparative analysis aimed to assess and compare antibiotic prescription trends in Italy across two different regions based on geographic area and healthcare structure. One region represents a large hospital institution, while the other represents a populous local Italian health agency. The study also examined the impact of documented antibiotic stewardship programs and efforts to promote responsible antibiotic use at all levels, in alignment with international goals. Antibiotic consumption data were collected from the Umberto I Polyclinic Hospital and the ASL Napoli 3 South Local Health Agency. Methods: To compare consumption between regions, a standardized comparison using the Defined Daily Dose (DDD) was employed. The internal management system of each healthcare facility records all prescriptions and drug dispensations, and these data were extrapolated for this retrospective study. Results: A comparative assessment between the first half of 2022 and 2023 (January–June) highlighted a significant increase in beta-lactam antibiotic consumption, showing a twofold rise compared to the previous year’s term. Regarding prescription averages, there was a noticeable increase of +29.00% in hospitalizations and +28.00% in hospital discharges within the ASL Napoli 3 South. Conversely, at Policlinico Umberto I, there was a marginal increase of +1.60% in hospitalizations and a decrease of −7.40% in hospital discharges. Conclusions: The study offers valuable insights into expenditure patterns and antibiotic consumption, underscoring the need for enhanced prescribing practices and awareness campaigns to address the issue of antibiotic resistance. The findings stress the importance of implementing international guidelines to combat the growing threat of antibiotic resistance and ensure the effective management of infectious diseases.

Publisher

MDPI AG

Reference39 articles.

1. European Commission (2023, October 01). Health Emergency Preparedness and Response Authority. Available online: https://health.ec.europa.eu/publications/hera-factsheet-health-union-identifying-top-3-priority-health-threats_it.

2. (2023, October 01). European Centre for Disease Prevention and Control, Available online: https://www.ecdc.europa.eu/en.

3. (2023, October 01). Italian Superior Institute of Health. Available online: https://www.iss.it/one-health.

4. (2023, October 01). Consiglio Unione Europea Bruxelles 1 Giugno 2023—“Raccomandazione del Consiglio sul Potenziamento Delle Azioni dell’UE per Combattere la Resistenza Antimicrobica con un Approccio “One Health””. Available online: https://health.ec.europa.eu/antimicrobial-resistance/eu-action-antimicrobial-resistance_it.

5. Italian Ministry of Health (2023, October 01). 2022 “Piano Nazionale di Contrasto all’Antibiotico-Resistenza (PNCAR) 2022–2025”, Available online: https://www.salute.gov.it/imgs/C_17_pubblicazioni_3294_allegato.pdf.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. The challenge of antimicrobial resistance (AMR): current status and future prospects;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3